Alan Skolnick News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alan Skolnick. Real-time updates on events, politics, business and more.

Veru Announces New England Journal of Medicine Evidence

July 6, 2022

- Phase 3 Clinical Study Met Primary and Key Secondary Endpoints - - Primary Endpoint: Sabizabulin Treatment Showed Statistically Significant and...

Source: globenewswire.com

July 6, 2022

After the results were first released in April, Veru asked the FDA for emergency use authorization of sabizabulin.

Source: cbsnews.com

April 14, 2022

Veru Inc (VERU) stock is up 1.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.

Source: techstory.in

April 13, 2022

Wall Street is growing more bullish on the biotech's prospects.

Source: fool.com